The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1 ##STR00001## and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.

The present invention relates to novel pharmaceutical compositions based on anticholinergics and endothelin antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.

Disclosed herein is the use of epinastine for the treatment of pain, including migraine, Bing-Horton syndrome, tension headaches, muscle pain, inflammatory pain, and neuralgias. Epinastine may also be administered in combination with an additional analgesic for treating pain.

Novel N-cyclohexylbenzamide derivatives of formula: ##STR1## where R.sub.1 represents an alkoxy radical capable of cyclizing with the aromatic ring; R.sub.2, R.sub.3 and R.sub.4 each independently represent hydrogen, a halogen or an alkoxy, amino, alkylamino or alkyl-carbonylamino group, and Z represents a differently substituted piperidinyl group; and their addition salts with pharmaceutically acceptable acids. The compounds of formula I are powerful gastrointestinal motility stimulants.

The present invention relates to new medicament compositions based on anticholinergic compounds, which have a long-lasting effect, and .beta.-mimetics, which have a long-lasting effect, processes for their production and their use in the therapy of respiratory ailments.

The present invention relates to new medicament compositions based on anticholinergic compounds, which have a long-lasting effect, and .beta.-mimetics, which have a long-lasting effect, processes for their production and their use in the therapy of respiratory ailments.

A pharmaceutical composition comprising: (a) an anticholinergic of formula 1 ##STR00001## wherein X.sup.- is an anion with a single negative charge; (b) a corticosteroid; and (c) a betamimetic, wherein each component (a), (b), and (c) are optionally in the form of the solvates or hydrates thereof, processes for preparing them, and their use in the treatment of respiratory diseases.

The present invention relates to new medicament compositions based on anticholinergic compounds, which have a long-lasting effect, and salmeterol, processes for their production and their use in the therapy of respiratory ailments.

The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK.sub.1 -receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.

The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK.sub.1 -receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.